INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M909. A total of 2 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $31,000 | +210.0% | 2,300 | -39.5% | 0.00% | – |
Q2 2017 | $10,000 | -68.8% | 3,800 | -52.5% | 0.00% | – |
Q1 2017 | $32,000 | -8.6% | 8,000 | -4.8% | 0.00% | – |
Q4 2016 | $35,000 | -20.5% | 8,400 | +29.2% | 0.00% | – |
Q3 2016 | $44,000 | -94.3% | 6,500 | -95.2% | 0.00% | -100.0% |
Q2 2016 | $776,000 | -19.9% | 134,200 | -3.3% | 0.01% | -35.7% |
Q1 2016 | $969,000 | +3626.9% | 138,800 | +3755.6% | 0.01% | – |
Q4 2015 | $26,000 | -7.1% | 3,600 | +12.5% | 0.00% | – |
Q3 2015 | $28,000 | -64.1% | 3,200 | -33.3% | 0.00% | -100.0% |
Q2 2015 | $78,000 | – | 4,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIMPLEX TRADING, LLC | 7 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 8,400 | $35,000 | 0.00% |